Market Tracker

08/27 12:55pm ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

16.23
Real-Time Quote
 +0.04 / +0.25%
Today’s Change
8.57
Today|||52-Week Range
20.29
+73.77%
Year-to-Date

Today’s Trading

Previous close16.19
Today’s open16.26
Day’s range15.98 - 16.47
Volume291,245
Average volume (3 months)520,080
Market cap$1.2B
Dividend yield--
Data as of 12:40pm ET, 08/27/2014

Growth & Valuation

Earnings growth (last year)-962.50%
Earnings growth (this year)-13.53%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-94.51%
P/E ratioNM
Price/Sales214.35
Price/Book9.06

Competitors

 Today’s
change
Today’s
% change
INSYInsys Therapeutics I...-0.91-2.56%
EPZMEpizyme Inc-0.82-2.24%
KPTIKaryopharm Therapeut...-0.52-1.34%
ACHNAchillion Pharmaceut...-0.16-1.36%
Data as of 12:55pm ET, 08/27/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$2.9M
Annual profit (last year)-$46.1M
Net profit margin-1,578.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin C. Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts